McKesson Corporation vs Pinterest Inc — how do they compare? McKesson Corporation trades at $940.73 (market cap $108.46B), while Pinterest Inc trades at $21.45 (market cap $11.63B). The key difference: McKesson Corporation is far larger — about 9.3× Pinterest Inc's market cap, and McKesson Corporation pays a 0.4% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Pinterest Inc for 85 Days on average.
| MCK | PINS | |
|---|---|---|
Market Cap | $108.46B | $11.63B |
Volume | 712,607 | 12,792,940 |
Sector | Health | Media |
52-Week High | $995.69 | $35.24 |
52-Week Low | $725.17 | $15.42 |
Typical Hold Time | 74 Days | 85 Days |
Enterprise Value | $115.00B | $11.55B |
Dividend Yield | 0.4% | — |
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $937.98, up 3.04% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent positive developments include the CVS Health partnership extension through 2032 and raised full-year guidance. Revenue growth remains robust at $359.05 billion for 2025, though net margins are thin at 1.12%.
The outlook remains positive with 81% analyst buy ratings and a $956.43 consensus target. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. Strong cash flow generation ($6.09B operating cash flow) supports the dividend and growth initiatives, while technical indicators show the stock testing resistance near $938.
Pinterest (PINS) trades at $21.35, up 5.1% today, showing strong momentum after three consecutive earnings beats. The stock maintains a bullish technical outlook with positive moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, revenue growth accelerated to $4.22 billion in 2025 with improving profitability, though valuation multiples remain elevated with a P/E of 60.4. Recent news highlights the company's visual search ad innovations and international monetization progress.
The outlook remains positive with 54% analyst buy ratings and a $27.93 consensus price target representing 31% upside. Key opportunities include continued international ARPU growth and AI-driven advertising enhancements. Risks include competitive pressure from larger platforms, potential advertising slowdowns, and insider selling activity that may signal caution among company leadership.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →